Concepedia

Baishan Jiang

BJ

Statistics

Publications

34

Citations

3K

H-Index

21

Active since

2010

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Zhongnan Hospital of Wuhan University

Chinese Academy of Sciences

Wuhan University

Baishan Jiang is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2010–2025

34

Publications

34

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

Baishan Jiang, Michael A. Erb, Yanke Liang et al. · Nature Chemical Biology · 2017 · 550 citations · Full text

, , +8

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development

Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman et al. · Cell · 2020 · 371 citations · Full text

, , +2

Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6

Baishan Jiang, Eric S. Wang, Katherine A. Donovan et al. · Angewandte Chemie International Edition · 2019 · 260 citations · Full text

, , +14

Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML

Matthias Brand, Baishan Jiang, Sophie Bauer et al. · Cell chemical biology · 2018 · 252 citations · Full text

, , +7

MELK is not necessary for the proliferation of basal-like breast cancer cells

Hai‐Tsang Huang, Hyuk‐Soo Seo, Tinghu Zhang et al. · eLife · 2017 · 194 citations · Full text

, , +17

1–5 of 34